Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| PVLA | PRESS-RELEASE | bullish | 7/10 | Palvella Therapeutics announced FDA acceptance and Priority Review of its NDA for QTORIN rapamycin for microcystic lymph | Oct 28, 2026 |
| MGN | 6-K | neutral | 4/10 | Megan Holdings Ltd. disclosed in a 6-K filing that two putative securities class actions were filed against it in July 2 | Oct 28, 2026 |
| PVLA | 8-K | bullish | 6/10 | Palvella Therapeutics announced that the FDA has accepted its NDA for QTORIN 3.9% rapamycin anhydrous gel for microcysti | Oct 28, 2026 |
| SYBT | 8-K | bullish | 6/10 | Stock Yards Bancorp reported record Q3 2026 net income of $43.5M ($1.40 diluted), up from $36.2M ($1.23) a year ago, dri | Oct 28, 2026 |
| EXTR | 8-K | bullish | 6/10 | Extreme Networks reported Q1 FY2027 revenue of $341.1M, up 10% YoY, and non-GAAP EPS of $0.33, up 50% YoY, with SaaS ARR | Oct 28, 2026 |
| CMRE | 6-K | neutral | 5/10 | Costamare reported Q3 2026 results with voyage revenue of $212.1M (down 1.8% YoY) and GAAP EPS from continuing operation | Oct 28, 2026 |
| CMRE | PRESS-RELEASE | neutral | 5/10 | Costamare reported Q3 2026 adjusted EPS of $0.74, above the $0.66 consensus, on voyage revenue of $212.1M (vs. $209.1M c | Oct 28, 2026 |
| IP | 8-K | bullish | 6/10 | International Paper reported Q3 2026 adjusted operating EPS of $0.37, beating the $0.29 consensus, and revenue of $6.20B | Oct 28, 2026 |
| DBD | 8-K | bearish | 6/10 | Diebold Nixdorf reported Q3 2026 revenue of $994.3M (up 5.2% YoY) and adjusted EPS of $1.34, slightly above the $1.31 co | Oct 28, 2026 |
| HSBC | 6-K | neutral | 3/10 | HSBC Holdings plc announced a $1 billion share buy-back program, commencing 29 October 2026 and ending no later than 19 | Oct 28, 2026 |
| FNMA | 8-K | neutral | 5/10 | Fannie Mae reported Q3 2026 net income of $4.2 billion, up 5% from $4.0 billion in Q2 2026 and up 8% from $3.9 billion a | Oct 28, 2026 |
| ENTA | 8-K | neutral | 3/10 | Enanta Pharmaceuticals announced the planned retirement of CEO Jay R. Luly by February 1, 2027, after 23 years, and the | Oct 28, 2026 |
| RDWR | 144 | neutral | 3/10 | Two Radware officers filed Form 144 notices of intent to sell shares on the same day. Riki Goldriech (Officer) plans to | Oct 28, 2026 |
| FLEX | 8-K | bullish | 6/10 | Flex reported Q2 FY2027 net sales of $8.5B, up 25% YoY, and record adjusted EPS of $1.18, beating the consensus estimate | Oct 28, 2026 |
| BLKB | 8-K | neutral | 5/10 | Blackbaud reported Q3 2026 revenue of $292.6M (+4.1% YoY) and non-GAAP EPS of $1.36, above the $1.33 consensus. The comp | Oct 28, 2026 |
| ETSY | 8-K | bullish | 5/10 | Etsy reported Q3 2026 revenue of $692.5M (+10.9% YoY) and GAAP diluted EPS of $1.00 from continuing operations, accelera | Oct 28, 2026 |
| RRC | 425 | neutral | 5/10 | Range Resources filed its Q3 2026 earnings release alongside the pending all-stock acquisition by EQT Corporation. GAAP | Oct 28, 2026 |
| LFUS | 8-K | bullish | 6/10 | Littelfuse reported record Q3 2026 net sales of $767M (up 23% reported, 22% organic YoY) and record adjusted diluted EPS | Oct 28, 2026 |
| VISM | SC 13D/A | neutral | 3/10 | Paul R. Taylor files this Amendment No. 1 to his Schedule 13D to correct and withdraw his prior filing. He states that t | Oct 28, 2026 |
| FLEX | PRESS-RELEASE | bullish | 6/10 | Flex reported Q2 FY2027 adjusted EPS of $1.18, beating the $1.06 consensus by 11.3%, and revenue of $8.5B, above the $8. | Oct 28, 2026 |
| REPL | 8-K | neutral | 5/10 | Replimune reported fiscal Q2 2027 results with a net loss of $57.1M ($0.54 per share), narrower than the $83.1M loss in | Oct 28, 2026 |
| MLYS | PRESS-RELEASE | bullish | 6/10 | Mineralys Therapeutics announced positive Phase 2 Explore-CKD results for lorundrostat, published in Kidney Internationa | Oct 28, 2026 |
| AMRN | 8-K | neutral | 5/10 | Amarin reported Q3 2026 GAAP net income of $0.2M, its first profitable quarter in over two years, versus a net loss of $ | Oct 28, 2026 |
| OTLY | 6-K | bearish | 5/10 | Oatly reported Q3 2026 revenue of $243.1M, up 9.1% YoY, and an operating loss of $9.2M, a significant improvement from a | Oct 28, 2026 |
| QBTS | 8-K | neutral | 3/10 | D-Wave Quantum Inc. announced a non-binding MOU with LG CNS to advance quantum computing adoption for enterprise optimiz | Oct 28, 2026 |
| TEX | 8-K | bullish | 6/10 | Terex reported Q3 2026 adjusted EPS of $1.50, beating the $1.42 consensus by 5.6%, on pro forma revenue growth of 11.6% | Oct 28, 2026 |
| AXGN | 8-K | bullish | 6/10 | Axogen reported Q3 2026 revenue of $75.8M (+26.2% YoY), above the $73.2M consensus, and GAAP net income of $2.3M ($0.04 | Oct 28, 2026 |
| HAYW | 8-K | bullish | 6/10 | Hayward Holdings reported Q3 fiscal 2026 results with net sales up 6% YoY to $260.1M and adjusted diluted EPS up 29% to | Oct 28, 2026 |
| SCL | PRESS-RELEASE | neutral | 2/10 | Stepan Company declared a Q4 2026 quarterly cash dividend of $0.405 per share, a $0.01 increase from the prior quarter, | Oct 28, 2026 |
| OTLY | 6-K | bearish | 6/10 | Oatly reported Q3 2026 revenue of $243.1M (+9.1% YoY), in line with the $243.5M consensus, and a GAAP net loss per ADS o | Oct 28, 2026 |